- £2.16bn
- £3.65bn
- $546.09m
- 36
- 46
- 38
- 30
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 7.73 | ||
PEG Ratio (f) | 0.19 | ||
EPS Growth (f) | 67.66% | ||
Dividend Yield (f) | 0.92% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 1.23 | ||
Price to Tang. Book | 1.3 | ||
Price to Free Cashflow | 13.74 | ||
Price to Sales | 5.44 | ||
EV to EBITDA | 13.09 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 6.33% | ||
Return on Equity | 6.22% | ||
Operating Margin | 71.53% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | 327.86 | 217.83 | 319.23 | 1,086.9 | 546.09 | 721 | 766.5 | 0.39% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -52.8 | n/a | n/a | +1511.9 | -76.53 | +156.58 | +9.99 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Burford Capital Limited is a global finance and asset management company focused on law. The Company’s businesses include litigation finance and risk management, asset recovery and a range of legal finance and advisory activities. It provides capital, based on portfolio size, against the underlying value of litigation and legal assets. It operates through two segments: Principal Finance and Asset Management and Other Services. The Principal Finance segment funds capital to legal finance assets from its balance sheet, primarily as capital provision assets, and in limited scope through interests in private funds managed the Company. These capital provision assets and private fund interests generate its capital provision income. The Asset Management and Other Services segment manages legal finance assets on behalf of third-party investors, and it provides other services to the legal industry. Its clients are a range of litigants including a number of law firms and businesses.
Directors
- Peter Middleton NEC
- Christopher Bogart CEO (55)
- Hugh Wilson NVC (73)
- Kenneth Brause CFO (56)
- Mark Klein CAD (53)
- Jonathan Molot CIN (54)
- Craig Arnott OTH (53)
- Elizabeth O'Connell OTH (53)
- David Perla OTH (50)
- Aviva Will OTH (52)
- Robert Gillespie NID (65)
- Andrea Muller NID (61)
- Charles Parkinson NID (67)
- John Sievwright NID (66)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 11th, 2009
- Public Since
- October 21st, 2009
- No. of Employees
- 160
- Sector
- Investment Banking & Investment Services
- Industry
- Financials
- Exchange
London Stock Exchange
- Shares in Issue
- 218,662,589

- Address
- 350 Madison Avenue, NEW YORK, 10017
- Web
- https://www.burfordcapital.com/
- Phone
- +1 2122356820
- Contact
- Robert Bailhache
- Auditors
- KPMG LLP
Latest News for BUR
Upcoming Events for BUR
Dividend For BURF.L - 6.2500 USX
Burford Capital Ltd Corporate Call
Half Year 2025 Burford Capital Ltd Earnings Release
Similar to BUR
3i
London Stock Exchange
450
London Stock Exchange
Aberdeen
London Stock Exchange
Achilles Investment Co
London Stock Exchange
Agronomics
London Stock Exchange
FAQ
As of Today at 19:44 UTC, shares in Burford Capital are trading at 1,023.00p. This share price information is delayed by 15 minutes.
Shares in Burford Capital last closed at 1,023.00p and the price had moved by -9.15% over the past 365 days. In terms of relative price strength the Burford Capital share price has underperformed the FTSE All Share Index by -11.68% over the past year.
The overall consensus recommendation for Burford Capital is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Burford Capital dividend yield is 0.92% based on the trailing twelve month period.
Last year, Burford Capital paid a total dividend of $0.13, and it currently has a trailing dividend yield of 0.92%.Looking ahead, shares in Burford Capital are due to go ex-dividend on 2025-05-23 and the next dividend pay date is 2025-06-13.
Burford Capital are due to go ex-dividend on 2025-05-23 and the next dividend pay date is 2025-06-13. The historic dividend yield on Burford Capital shares is currently 0.92%.
To buy shares in Burford Capital you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 1,023.00p, shares in Burford Capital had a market capitalisation of £2.24bn.
Here are the trading details for Burford Capital:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: BUR
Based on an overall assessment of its quality, value and momentum Burford Capital is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Burford Capital is 1,922.85p. That is 87.96% above the last closing price of 1,023.00p.
Analysts covering Burford Capital currently have a consensus Earnings Per Share (EPS) forecast of $1.69 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Burford Capital. Over the past six months, its share price has underperformed the FTSE All Share Index by -8.88%.
As of the last closing price of 1,023.00p, shares in Burford Capital were trading -2.79% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Burford Capital PE ratio based on its reported earnings over the past 12 months is 7.73. The shares last closed at 1,023.00p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Burford Capital's management team is headed by:
- Peter Middleton - NEC
- Christopher Bogart - CEO
- Hugh Wilson - NVC
- Kenneth Brause - CFO
- Mark Klein - CAD
- Jonathan Molot - CIN
- Craig Arnott - OTH
- Elizabeth O'Connell - OTH
- David Perla - OTH
- Aviva Will - OTH
- Robert Gillespie - NID
- Andrea Muller - NID
- Charles Parkinson - NID
- John Sievwright - NID